Patent · US Active

Pharmaceutical composition containing nicotinic acid and/or nicotinamide for beneficially influencing blood lipid levels by modifying the intestinal microbiota

US10888555B2 · kind B2 · utility

0Cited by

2References

30Claims

0Family size

Assignee

CONARIS Research Institute AG · DE

Inventors

Georg H. Wätzig · Kiel, DE
Dirk Seegert · Dänischenhagen, DE

Key dates

Filing date	Dec 12, 2014
Grant date	Jan 12, 2021
Priority date	—
Expiry date	Dec 12, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a new pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or related compounds for beneficially influencing the intestinal microbiota and blood lipid levels. In certain embodiments, the pharmaceutical composition is partially or entirely released into the lower small intestine and/or large intestine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.